Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance ResearchGlobeNewsWire • Thursday
23ANDME INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates 23andMe Holding Co. - MEBusiness Wire • 07/19/24
23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker PanelGlobeNewsWire • 06/28/24
Levi & Korsinsky Reminds 23andMe Consumers of an Investigation into Recent Data BreachAccesswire • 06/06/24
23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual MeetingGlobeNewsWire • 06/03/24
Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and historyGlobeNewsWire • 05/29/24
Petros Pharmaceuticals Launches U.S. Distribution of Prescription ED Medication STENDRA Through Recently Announced Collaboration With Lemonaid Health, a Subsidiary of 23andMeAccesswire • 05/14/24
Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros PharmaceuticalsGlobeNewsWire • 05/14/24
Potter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach CaseBusiness Wire • 04/30/24